IGC Pharma Launches PRISM Application Layer for Alzheimer’s AI
IGC Pharma said PRISM will move its MINT-AD Alzheimer’s AI from prediction toward actionable workflows. B2B, B2B2C and online commercialization are under evaluation.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
IGC Pharma said PRISM will move its MINT-AD Alzheimer’s AI from prediction toward actionable workflows. B2B, B2B2C and online commercialization are under evaluation.